Solos Endoscopy declared that it will launch SteriTAP, a new line of endoscopic instruments. Designed to be the ultimate take-apart sterile endoscopic instruments, Solos' SteriTAP Instruments will be commercialized globally by Solos Endoscopy.
Solos Endoscopy, on receiving its proper certifications, will market Solos' SteriTAP instruments in various countries.These instruments have now been validated to get the CE Mark approval.
Reportlinker stated that there is a growing demand for endoscope services as the world witnesses an increased population of chronically ill and aged patients. This market also represents upgrades in endoscopic technologies, real-time conversion of data into 3-D images and innovative integration of a variety of video cameras and lighting sources. The diagnosis and treatment of cancer patients have become more effective by implementing endoscopy techniques. Endoscopy have evolved as the gold standard for diagnosis and treatment of cancer and even for other medical conditions.
The minimally invasive surgical (MIS) procedures such as endoscopy are gaining acceptance and being established in the overall medical arena due to the following reasons:
- Endoscopic procedures are more cost-effective compared to related counterparts in traditional surgery.
- It is effective for treating conditions where patients require only minimal sedation and not full anesthesia.
- Patients undergoing endoscopic procedures experience only reduced post surgery monitoring time.
- These procedures ensure rapid recuperation time. The period of post-surgical hospital stay is less, thereby reducing the associated ancillary costs.